International Federation for Medical and Biological Engineering

Disclaimer:
Information regarding a non-State actor, contained in the section “Non-State Actors Profiles” in the Register, has been provided by that non-State actor itself, and the accuracy and completeness of such information is the sole responsibility of that non-State actor, not WHO. In turn, information in the sections “WHO’s Engagement” and “Non-State Actors in Official Relations” has been provided by WHO, subject to certain conditions. All access and use of any section of the Register is governed by the Terms and Conditions of Use.

 Overview

International Federation for Medical and Biological Engineering
IFMBE
IFMBE is the federation of national and transnational societies on biomedical engineering
http://www.ifmbe.org
23 Oct 2021 07:16:40 PM

 General information

International Federation for Medical and Biological Engineering
IFMBE
IFMBE
International Federation for Medical and Biological Engineering
IFMBE
Fédération Internationale pour le Génie Biomédical
IFMBE is the federation of national and transnational societies on biomedical engineering
Focal Point IFMBE (Marc Nyssen)
JB Vandercammenstraat 25
Oudergem
Brussels
B-1160
Belgium
http://www.ifmbe.org

 Governance

International not for profit organisation
1959
Administrative Council
Krishnan Shankar (President)
North-­‐America Regional Group Representative
Wentworth University Boston
Monique Frize
Chair of Council of Societies
University of Ottawa
Bruce C.,WHEELER
Member
University of California San Diego
Igor LACKOVIC
Member
University of Zagreb
Ratko Magjarevic (President Elect)
Member
University of Zagreb
Gilda Barabino
Member
USA
Peter HUNTER
Member
University of Auckland
Ichiro Sakuma
Asian-­‐Pacific Working Group Representative
Japan
Eric Laciar Leber
Latin-­‐America Regiona Representative
University of Valparaiso
Timo JÄMSÄ
Europe-­‐Africa Regional Group Representative
University of Oulu
Tom Judd
Chair of Clinical Engineering Division
USA
Ernesto Iadanza
Chair of Health Technology Division
University of Pisa
James Goh
Former President
National University Singapore
Martha Zequera Diaz
Member
University of Bogota
Jari Hyttinen
Member
Finland
Council members
Officers of the Federation
Krishnan Shankar
President
Wentworth University Boston
Kang Ping Lin
Secretary General
Chung-Yuan Christian University, Taiwan, China
James Goh
Former President
National University Singapore
Ratko Magjarevic
President Elect
University of Zagreb
Marc Nyssen
Treasurer
Free University Brussels
Daily management of the Federation
General Assembly
All regular member associations have vote(s) in the General Assembly. This is the most supreme international decision making body.
Approval of budget, strategic plan, policy direction, policy statements. See constitution

 Financial information

January
2020
January
2021
257,357
January
2021
285,000
Private sector entities (including business associations)
Philanthropic foundations
NGOs, academic institutions
Government entities, intergovernmental organizations, including UN
General public, individuals
Total
224,435
224,435
26,346
26,346
110
110
250,891
250,891
Income from scientific publications (peer reviewed journal and conference publications) and from conferences

 Membership

Individuals
0
0
NGOs
72
72
Private sector entities
0
0
Philanthropic foundations
0
0
Academic institutions
0
0
Government entities
0
0
Intergovernmental organizations
0
0
http://ifmbe.org/members/members/

Organizational Structure

No data available
Not for profit international organisation
No data available
none

Relations

No data available
International Union for Physical and Engineering Sciences in Medicine (IUPESM)
Member of
World Federation of Engineering Organisations(WFEO)
Member of
No data available
National Biomedical Engineering societies
Transnational Biomedical Engineering societies

  Activities

The mission of the IFMBE is to encourage, support, represent and unify the world-wide Medical and Biological Engineering community in order to promote health and quality of life through advancement of research, development, application and management of technology.
Strategic Priority 1: One billion more people benefiting from universal health coverage
Strategic Priority 2: One billion more people better protected from health emergencies
Strategic Priority 3: One billion more people enjoying better health and well-being
Strategic Priority 4: More effective and efficient WHO providing better support to countries
Medical Devices
Clinical Engineering
Health Technology Assessment

  Country presence

Regions
Countries
Activities
Members
Offices / representatives
African Region
Region of the Americas
Eastern Mediterranean Region
European Region
South-East Asia Region
Western Pacific Region
Global

  Disclosure & declaration

Pursuant the WHO Framework of Engagement with Non-State Actors, WHO does not engage with the tobacco industry or non-State actors that work to further the interests of the tobacco industry. WHO also does not engage with the arms industry.

For the purposes of this statement:

  • tobacco industry means any entity involved in the manufacture, sale or distribution of tobacco and related products, and any affiliate of such entity; and
  • arms industry means any entity involved in the manufacture, sale or distribution of arms, and any affiliate of such entity.

This disclosure statement needs to be provided by any nongovernmental organization, private sector entity, philanthropic foundation and academic institution prior to engaging with WHO.

In view of the foregoing, please answer the following questions:

  1. Is your entity, or was your entity over the last four years, part of the tobacco or arms industries (as defined above)?
  1. To the best of your entity’s knowledge, is your entity, or has your entity over the last four years, engaged in activities that are aimed at furthering or supporting the interests of the tobacco industry? This includes, but is not limited to, supply contracts, contract work, services and lobbying.
  1. To the best of your entity’s knowledge, does your entity currently, or did your entity over the last four years, have any other association or relationship with the tobacco industry (as defined above). This includes in particular investment interests (other than general mutual funds or similar arrangements whereby your entity has no control over the selection of the investments), commercial business interests, the provision or receipt of financial and/or other support.
  1. If you have answered yes to any of the above or are unable to answer one or more questions, please provide a general statement of explanation.

Please note that the WHO Secretariat reserves the right to request additional information from your entity in this regard.
By providing this statement, your entity commits to promptly inform WHO of any change to the above information and to complete a new statement that describes the changes.